Want to join the conversation?
$OMC said that the strength in the dollar continues to create a negative FX headwinds on its revenue. For 2Q16, the reduction was 1.6% overall or about $63MM and with net acquisitions added, it was 0.3% to revenue this quarter. EBITDA rose 4.3% to $590MM and EBITDA margin was 15.2% for the quarter, representing a 30 BP increase over 2Q15.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?